Larson Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Larson Financial Group's BIIB Position: Q2 2026 in Review
Larson Financial Group increased its Biogen (BIIB) stake by 4.9% in Q2 2026, buying an estimated $8.23K and bringing the position to 924 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #849.
Larson Financial Group first reported a position in BIIB in Q4 2018 and has held it in 23 quarters since. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Larson Financial Group held 924 shares of Biogen worth $200K as of Q2 2026.
- Larson Financial Group bought 43 Biogen shares in Q2 2026, an estimated $8.23K.
- Biogen made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #849 holding.
- Larson Financial Group first reported a position in Biogen in Q4 2018 and has held it in 23 quarters since.
- 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.